Skip to main content

Mitchell T. Wallin, MD, MPH

Academic Title:

Clinical Associate Professor

Primary Appointment:



100 South Paca Street, 3rd Floor, 3-116, Baltimore, MD 21201

Phone (Primary):




Education and Training

  • Wheaton College, BS, Biology
  • University of Minnesota School of Medicine, MD
  • Johns Hopkins University School of Hygiene and Public Health, MPH
  • Northwestern University-Chicago, Internal Medicine Internship
  • University of Minnesota-Minneapolis, Neurology Residency
  • Johns Hopkins University, Preventive Medicine & Public Health Residency


Dr. Wallin in a nationally recognized clinician-scientist specializing in multiple sclerosis (MS), epidemiology, and global health. He was mentored by Dr. John Kurtze and has co-authored over 100 peer-reviewed articles, book chapters and reviews. Dr. Wallin’s research and writing over the past 20 years have been supported by the National MS Society, Department of Veterans Affairs (VA) Merit Review system, NIH and other sources.

He currently directs the VA MS Center of Excellence-East and received the Mark Wolcott Award for Clinical Leadership for innovations in neurological care, telemedicine and health policy. He chairs the US Multiple Sclerosis Prevalence Workgroup funded by the National MS Society which produced a nationally representative MS prevalence estimate for the US utilizing a novel dataset algorithm.

Dr. Wallin serves as a neurology consultant to the Global Burden of Disease Study Group and is a neurology attending at the University Teaching Hospital-Lusaka-University of Zambia.  He is board certified in neurology and preventive medicine and public health.

Research/Clinical Keywords

Multiple Sclerosis, Neuroepidemiology, Global Health, Neuroinfections, Telemedicine

Highlighted Publications

Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG. US Multiple Sclerosis Prevalence Workgroup. The prevalence of MS in the United States: A population-based estimate using health claims data. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019;92:e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15. PubMed PMID: 30770430.

GBD 2015 Multiple Sclerosis Collaborators (Wallin, MT, et al). Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.  Lancet Neurol. 2019;18:269-285. doi: 10.1016/S1474-4422(18)30443-5. Epub 2019 Jan 21. PubMed PMID: 30679040.

Wallin MT, Oh U, Nyalwidhe J, Semmes J, Kislinger T, Coffman P, Kurtzke JF, Jacobson S. Serum proteomic analysis of a pre-symptomatic multiple sclerosis cohort. Eur J Neurol. 2015 Mar;22(3):591-9. doi: 10.1111/ene.12534. Epub 2014 Aug 7. PubMed PMID: 25104396.

Wallin MT, Pretell EJ, Bustos JA, Caballero M, Alfaro M, Kane R, Wilken J, Sullivan C, Fratto T, Garcia HH. Cognitive changes and quality of life in neurocysticercosis: a longitudinal study. PLoS Negl Trop Dis. 2012 Jan;6(1):e1493. doi: 10.1371/journal.pntd.0001493. Epub 2012 Jan 31. PubMed PMID: 22303492.

Wallin MT, Culpepper WJ, Coffman P, Pulaski S, Maloni H, Mahan CM, Haselkorn JK, Kurtzke JF. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.Brain. 2012 Jun;135(Pt 6):1778-85. doi: 10.1093/brain/aws099. PubMed PMID: 22628389.